Bristol-Myers price target lowered to $72 from $78 at Credit Suisse

Credit Suisse analyst Trung Huynh lowered the firm’s price target on Bristol-Myers to $72 from $78 and keeps a Neutral rating on the shares. Bristol-Myers had a solid Q1 print, with no surprises as guidance was reiterated for FY23, the analyst tells investors in a research note.